Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02781350
Other study ID # 1955
Secondary ID
Status Completed
Phase N/A
First received April 25, 2016
Last updated May 23, 2016
Start date November 2010
Est. completion date May 2013

Study information

Verified date May 2016
Source University at Buffalo
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The main objective of this research is to investigate the effect of addition of fiber on the high fat high carbohydrate (HFHC) meal induced inflammation and oxidative stress mechanisms at the molecular level in humans, in vivo. The investigators have previously shown that the intake of one HFHC meal leads to an increase in oxidative stress and inflammation. HFHC meal also induces an increase in the expression of suppressor of cytokine signaling- 3 (SOCS-3) in the mononuclear cells (MNC), which interferes with insulin signal transduction and contributes to the pathogenesis of insulin resistance. In contrast, an American heart association (AHA) meal rich in fruits and fiber does not induce these effects. These observations are important since HFHC meal not only induces oxidative stress and inflammation but also lays the foundations of a potentially greater insulin resistance through the induction of SOCS-3, TLR-4 and TLR-2.


Description:

The main objective of this research is to investigate the effect of high fat high carbohydrate (HFHC) meal on inflammatory mechanisms at the molecular level in humans, in vivo versus HFHC meal plus fiber. HFHC meal includes egg muffin, sausage muffin sandwiches and two hash browns. The Investigators have previously shown that the intake of one HFHC meal leads to an increase in reactive oxygen species (ROS) generation and the expression of p47, the key subunit of NADPH oxidase, with a concomitant increase in intranuclear nuclear factor κB (NFkB) binding. More recently, the investigators have also shown that HFHC meal leads to an increase in plasma endotoxin (lipopolysaccharide, LPS) concentrations along with an increase in the expression of Toll like receptor-4 (TLR-4), the receptor for endotoxin, and TLR-2, the receptor for several products of Gram positive bacteria. In addition, it also causes an increase in lipopolysaccharide binding protein (LBP), the protein which facilitates the binding of LPS to CD14 and TLR-4. Finally, HFHC meal also induces an increase in the expression of suppressor of cytokine signaling- 3 (SOCS-3) in the mononuclear cells (MNC) (1), which interferes with insulin signal transduction and contributes to the pathogenesis of insulin resistance. In contrast, an AHA meal does not induce these effects. These observations are important since HFHC meal not only induces oxidative stress and inflammation but also lays the foundations of (2) a potentially greater response to an inflammatory challenge through the induction of an increase in LPS concentrations and the expression of TLR-4 and TLR-2; and (3) insulin resistance through the induction of SOCS-3, TLR-4 and TLR-2.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date May 2013
Est. primary completion date May 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Age: 18 to 80 years of age

- Subject will be available for duration of the study and willing to comply with all study requirements

- Written and informed consent signed and dated

- Nonsmoker

Exclusion Criteria:

- Coronary artery disease (CAD): documented by history of myocardial infarction, angioplasty/stent placement, angina, exercise EKG positive for ischemia or angiographic evidence of CAD

- Patient on non-steroidal anti-inflammatory drugs or steroids

- Hepatic disease (transaminase > 3 times normal)

- Renal impairment (serum creatinine > 1.5 mg/dl)

- History of drug or alcohol abuse

- Participation in any other concurrent clinical trials

- Use of an investigational agent or therapeutic regimen within 30 days of study

- Pregnancy

- Premenopausal women who are trying to be pregnant

- Anemia

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Other:
HFHC meal
900 Cal high fat high carbohydrate fast food meal (HFHC). meal includes egg muffin and sausage muffin sandwiches and two hash browns which contain 88g carbohydrates, 51 g fat (33% saturated) and 34 g protein (carbohydrates 41%, protein 17%, and fat 42%).
Dietary Supplement:
HFHC MEAL plus Fiber
900 Cal high fat high carbohydrate fast food meal containing egg muffin and sausage muffin sandwiches and two hash browns which contain 88g carbohydrates, 51 g fat (33% saturated) and 34 g protein (carbohydrates 41%, protein 17%, and fat 42%).with FiberOne Original cereal 14 grams (half cup) each before and after the HFHC meal

Locations

Country Name City State
United States ECMC Ambulatory Center, 3rd Floor Buffalo New York

Sponsors (1)

Lead Sponsor Collaborator
University at Buffalo

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary effect of addition of fiber on the relative change of NF-Kappa B The investigators hypothesize that addition of fiber intake will suppress NF-kappa B after HFHC meal. Therefore, changes in NF-kappa B activity will be compared as percent change form baseline after HFHC meal with or without fiber in lean and obese subjects Baseline and 1 week No
Secondary effect of addition of fiber on Changes in ROS generation. Changes in Reactive oxygen species (ROS) generation between the 2 visits (HFHC meal with or without fiber) will be compared as percent change from baseline. Baseline and 1 week No
Secondary effect of addition of fiber on Changes in TLR-4 mRNA expression in MNC Changes in TLR-4 mRNA expression in MNC between the 2 visits (HFHC meal with or without fiber) will be compared as percent change from baseline. Baseline and 1 week No
Secondary effect of addition of fiber on Changes in SOCS-3 mRNA expression in MNC Changes in SOCS-3 mRNA expression in MNC between the 2 visits (HFHC meal with or without fiber) will be compared as percent change from baseline. Baseline and 1 week No
Secondary effect of addition of fiber on Changes in insulin secretion between the 2 visits (HFHC meal with or without fiber) will be compared as percent change from baseline. Changes in insulin concentrations between the 2 visits (HFHC meal with or without fiber) will be compared as percent change from baseline. Baseline and 1 week No
See also
  Status Clinical Trial Phase
Completed NCT00809874 - Effects of Dietary Proteins on Postprandial Lipaemia and Incretin Responses in Obese Subjects N/A
Completed NCT05017428 - Absorption and Digestion Kinetics of Human Metabolites N/A